On February 28, rare-disease communities around the world come together to advocate for an increase in research focused on rare diseases. When it comes to clinical research for rare and orphan diseases, the relationship with the patient and advocacy groups is critical to success.
clinical trial patient recruitment
Competing studies can be a challenge when enrolling patients in clinical trials. But when those studies are conducted by one sponsor, the need to engage with a single patient population can quickly turn into an asset and huge savings.
Clinical trial participation can be hindered by a variety of factors, many of which are compounded when the study focuses on children. Caregivers must consider what arrangements need to be made to accommodate participation. A UBC home health nurse discussed the challenges and opportunities one mother found when enrolling her child in a Phase II study.
Access to clinical trial information is driving more participation by volunteers, not just patients. This shift is also shining a light on the evolving motivations of clinical trial participants.
Even with all of the advances across the clinical research marketplace – EMR, social media, big data, mobile technology — the success of patient enrollment remains largely with the study site. So how can sponsors and sites work together to achieve enrollment goals?
Our Patient & Physician Services (PPS) team designs and implements customized patient recruitment and retention programs, call center initiatives, and digital strategies, all in support of clinical trials. These efforts translate into comprehensive, end-to-end clinical trial strategies for our manufacturer partners that often exceed expectations. Check out our latest blog to see how this team surpassed the enrollment deadline for a breast cancer study.